跳至主要内容
临床试验/NCT05034848
NCT05034848终止不适用

Peripheral Artery Disease (PAD) : Its Effects on Bone

Centre Hospitalier Régional d'Orléans2 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2021年3月31日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
2
试验地点
2
主要终点
Bone Mineral Density (BMD) volumic values at the tibias of PAD (Peripheral Artery Disease) patients

研究概览

简要总结

Prevalence of PAD and osteoporosis (OP) both get higher with age. Clinical and epidemiologic evidence have showed an increased cardiovascular risk in OP and bone loss and fragility fractures in patient with cardiovascular disease.

This study will examine the relationship between vascular disease in legs and sBMD and vBMD at trabecular and cortical sites and bone microarchitecture.

详细描述

The primary goal of our study is to determinate if presence of PAD is associated with lower sBMD and vBMD values at the tibias, assuming that BMD should be more alterate in the predominant vascular impairement site.

Our secondary objectives are to :

  • determine if severity of PAD quantified by ankle brachial index ABI is associated to a decrease of BMD values defined by T-Score at the left hip, spine and legs, but also with volumetric values, assessed by HRpQCT at the non dominant radius and at both tibias.
  • determine the prevalence of osteoporosis in our population
  • To evaluate the relationships between ;
  • lipids and bone parameters
  • vit D and parathormone with PAD severity
  • levels of physical activity and both vascular and bone impairments

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • PAD patients defined by an Ankle brachial index < 0.9
  • Written consent
  • Patient affiliated with a social security organism

排除标准

  • Age < 18 years
  • Pregnancy or risk of pregnancy
  • Patients Under guardianship
  • Patient with known PAD who had been previously treated by surgery or endovascular pathway

结局指标

主要结局

Bone Mineral Density (BMD) volumic values at the tibias of PAD (Peripheral Artery Disease) patients

时间窗: Day 0

BMD volumic values are BMD volumetric bone mineral density (mg HA/cm3)

次要结局

  • Bone Mineral Density (BMD) measurement by DXA(Day 0)
  • Comparison between microstructural parameters at tibias(Day 0)
  • Percentage of densitometric osteoporotic patients(Day 0)
  • Correlation between Lipid and bone parameters(Day 0)
  • Evaluation of cardiovascular risk(Day 0)
  • Correlation between microstructural parameters at tibias and radius(Day 0)
  • Correlation between microstructural parameters and ankle brachial index results(Day 0)
  • Evaluation of risk of fracture(Day 0)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验